← All Sponsors
SPONSOR

Jona Hattangadi-Gluth

Total Trials
1
Recruiting
1
Phases
Phase 2

Jona Hattangadi-Gluth is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Brain Metastases, Adult, Neurocognitive Function, Cancer.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Jona Hattangadi-Gluth

How many clinical trials has Jona Hattangadi-Gluth sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Jona Hattangadi-Gluth, of which 1 are actively recruiting participants. These trials cover conditions including Brain Metastases, Adult, Neurocognitive Function, Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jona Hattangadi-Gluth research focus on?
Jona Hattangadi-Gluth clinical trials span Brain Metastases, Adult, Neurocognitive Function, Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jona Hattangadi-Gluth clinical trial?
To participate in a Jona Hattangadi-Gluth trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jona Hattangadi-Gluth trials with current recruitment status updated daily.

Clinical Trials by Jona Hattangadi-Gluth

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology